基于基因疗法治疗脊柱肌肉缩的策略 - - 亚太地区的视角
Michelle A Farrar1,2, Loudella Calotes-Castillo3, Ranil De Silva4,5
1Department of Neurology, Sydney Children's Hospital Network, Sydney, New South Wales, Australia. m.farrar@unsw.edu.au.
Molecular and cellular pediatrics
|November 14, 2023
概括
奥纳森诺基尼阿贝帕尔沃维克 (Onasemnogene abeparvovec) 为脊柱肌肉缩 (SMA) 提供了一种改变生活的基因疗法. 成功实施需要临床医生教育,早期诊断和共同努力来解决接入和道德方面的考虑.
科学领域:
- 遗传学 遗传学 是一个
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 奥纳森诺基因阿贝帕尔沃维克 (Onasemnogene abeparvovec) 代表了罕见遗传疾病,如脊髓肌肉缩 (SMA) 的基因疗法的重大进展.
- 临床医生对基因疗法的理解对于SMA的有效治疗策略至关重要.
研究的目的:
- 审查色基因abeparvovec.的开发和临床翻译.
- 识别在医疗保健实践中实现其实施的促进者和障碍.
- 为了告知卫生系统对基因治疗的准备.
主要方法:
- 文献综述,重点关注 onasemnogene abeparvovec 的开发和临床试验.
- 对影响基因疗法在SMA护理中的实施因素的分析.
- 检查医疗系统对先进疗法的要求.
主要成果:
- 快速的SMA诊断,患者/临床医师教育和多学科专业知识是准备的关键.
- 跨部门合作和政策制定对于应对物流挑战至关重要.
- 现实世界的证据收集和研究支持的生态系统对于优化护理和未来疗法至关重要.
结论:
- 顺利整合onasemnogene abeparvovec需要解决伦理,公平,经济和可持续性问题.
- 全球合作对于推进基因疗法和最大限度地提高健康影响至关重要.
- 需要采取积极主动的方法来确保卫生系统的准备和临床管理.
更多相关视频
05:55Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
Published on: October 3, 2011
60.9K
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
7.7K
相关概念视频
01:21Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
00:59Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
01:20Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K